Skip to main content
GENETIC TECHNOLOGIES LIMITED logo

GENETIC TECHNOLOGIES LIMITED — Investor Relations & Filings

Ticker · GTG ISIN · AU000000GTG7 LEI · 529900YYKY7FRC90M744 ASX Human health and social work activities
Open in API
Filings indexed 1,303 across all filing types
Latest filing 2004-06-14 Capital/Financing Update
Country AU Australia
Listing ASX GTG

About GENETIC TECHNOLOGIES LIMITED

https://gtglabs.com/

Genetic Technologies Limited is a molecular diagnostics company focused on the development and commercialization of predictive genetic risk assessment tools. The company specializes in the geneType platform, which integrates clinical risk factors with polygenic risk scores to provide comprehensive risk assessments for various chronic diseases. Its portfolio includes tests for breast cancer, colorectal cancer, prostate cancer, melanoma, type 2 diabetes, and coronary artery disease. By identifying individuals at high risk of developing these conditions, the company enables healthcare providers to implement personalized screening and preventative health strategies. Genetic Technologies Limited serves clinicians and patients globally, aiming to improve health outcomes through early detection and precision medicine.

Recent filings

Filing Released Lang Actions
GTG Proceeds with its Strategic Alliance 3 pages ?Kb
Capital/Financing Update Classification · 95% confidence The document is a letter dated 15 June 2004 addressed to the Australian Stock Exchange announcing a strategic alliance between Genetic Technologies Limited (GTG) and the CY O'Connor ERADE Village Foundation (CYO). It details the terms of the alliance, including intellectual property assignments, funding commitments, share issuance, and licensing agreements. The content focuses on a corporate partnership and capital arrangement rather than financial results, regulatory compliance, or shareholder voting. The document length is 4440 characters, which is relatively short and reads as an announcement rather than a full report. There is no indication of financial statements, audit information, or meeting materials. The nature of the content fits best with a Capital/Financing Update (CAP) as it discusses share issuance and funding related to the strategic alliance. Therefore, the appropriate classification is CAP with high confidence.
2004-06-14 English
Appendix 3B-For CY O'Connor Erade Village Foundation 9 pages ?Kb
Capital/Financing Update Classification · 95% confidence The document is titled 'Appendix 3B' and is described as a 'New issue announcement, application for quotation of additional securities and agreement.' It details the issuance of new ordinary shares, the issue price, terms, and purpose related to satisfaction of a purchase price under an agreement. The document references ASX rules and includes detailed information about securities issued, options, and related terms. This type of document is a formal announcement of a capital raising or share issuance event, specifically notifying the stock exchange and shareholders about new securities being issued. It is not a full financial report, earnings release, or management discussion. It fits the category of Capital/Financing Update (CAP) as it provides updates on company fundraising and capital structure changes.
2004-06-14 English
Continues its Expansion into New Zealand 2 pages ?Kb
Regulatory Filings Classification · 95% confidence The document is a letter dated June 4, 2004, addressed to the Australian Stock Exchange Company Announcements Office. It announces the company's expansion activities into New Zealand, including new contracts, approvals, and marketing efforts. The content is an update on business developments rather than a financial report, regulatory filing, or management change. It does not contain financial statements, voting results, or executive compensation details. The document is a market announcement about business expansion and new contracts, which fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2004-06-03 English
GTG Appoints First Full Time Chief Financial Officer 1
Board/Management Information Classification · 100% confidence The document is a formal announcement dated 24 May 2004 from Genetic Technologies Limited to the Australian Stock Exchange. It announces the appointment of Mr. Tom Howitt as the company's first full-time Chief Financial Officer, effective 1 June 2004. The content focuses solely on management changes and does not contain financial data, report references, or other regulatory filings. The document length is short (2142 characters), and it is clearly an announcement of a management appointment rather than a report or financial disclosure. Therefore, the appropriate classification is Board/Management Information (MANG).
2004-05-23 English
GTG Grants Research License to Colorado State University 1
Regulatory Filings Classification · 95% confidence The document is a short announcement dated 20 May 2004 from Genetic Technologies Limited to the Australian Stock Exchange. It announces the granting of a research license to Colorado State University for non-coding patents. The content is a straightforward corporate announcement about licensing activity, with no financial data, no regulatory filings, no meeting materials, no voting results, no management changes, no earnings or financial reports, and no legal proceedings. It is not a report or a detailed presentation but a simple update on licensing activity. This fits best under the category of a general regulatory announcement or miscellaneous corporate update, which corresponds to Regulatory Filings (RNS). The document length is short (1302 characters), and it is not a report publication announcement or certification. Therefore, the classification is RNS with high confidence.
2004-05-19 English
Commitments Test Entity - Third Quarter Report 5 pages ?Kb
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Appendix 4C Quarterly report' and contains detailed financial data including consolidated cash flow statements for the quarter ended 31 March 2004. It includes operating, investing, and financing cash flows, payments to directors, reconciliation of cash, and compliance statements. The document is a quarterly financial report with substantive financial data and analysis, not merely an announcement or certification. This matches the definition of an Interim / Quarterly Report (IR).
2004-04-20 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.